期刊文献+

系统性红斑狼疮初发患者外周血T细胞免疫球蛋白及黏蛋白域蛋白-3及其配体半乳糖凝集素-9表达水平和意义 被引量:8

The expression and significance of T cell immunoglobulin domain and m ucin domain-3 and its ligand Galectin-9 in the peripheral blood of initial systemic lupus erythematosus patients
原文传递
导出
摘要 目的通过检测T细胞免疫球蛋白及黏蛋白域蛋白(TIM)-3及其配体半乳糖凝集素-9在系统性红斑狼疮(SLE)初发患者外周血的表达水平,探讨其在SLE发病中的可能作用。方法选取SLE初发患者33例,健康对照组26名,采用流式细胞术检测2组CD4+TIM-3+、CD8+TIM-3+细胞表达水平;实时荧光定量聚合酶链反应(PCR)技术比较2组外周血单个核细胞(PBMCs)半乳糖凝集素-9mRNA表达水平;同时记录SLE组SLE疾病活动指数(SLEDAI)、补体c3水平和外周血淋巴细胞计数。两独立样本比较采用Mann—WhitnevU检验;相关关系采用Spearman等级相关分析。结果SLE组CD4CFIM-3+、CD8+TIM-3+细胞比率显著高于对照组(P〈0.01);其中CD4+TIM-3+、CD8q'IM-3+细胞数目与SLEDAI呈正相关(r=0.517,P〈0.01;r=0.400,P〈0.05);与补体C3水平呈负相关(r-0.487,P〈0.05;r=-0.395,P〈0.05)。SLE组PBMCs半乳糖凝集素-9mRNA表达较对照组显著上调(P〈0.05)。结论TIM-3-半乳糖凝集素-9通路可能参与了SLET细胞免疫调节,并与疾病活动眭相关。 Objective To investigate the expression of T cell immunoglobulin domain and mucin domain (TIM)-3 and its ligand Galectin-9 in the peripheral blood of initial systemic lupus erythematosus (SLE) patients, and explore their effects on SLE. Methods The percentages of CD4CFIM-3+, CD8+TIM-3+ cells from 33 SLE patients and 26 normal controls were detected by flow cytometry, and the Galectin-9 gene expression of PBMCs was determined by real-time PCR. The SLE Disease Activity Index (SLEDAI), C3 level and lymphocyte count were evaluated. Mann-Whitney U test was used for independent samples analysis and Spearmen's test was used for correlation analysis. Results The percentages of CD4+TIM-3+ and CD8+TIM-3+ cells were markedly increased in SLE group than those of the control group (P〈0.01). In particular, the CD4+ TIM-3+, CD8+TIM-3+ level was positively correlated with SLEDAI (r=0.517, P〈0.01 ; r=0.400, P〈0.05); but negatively correlated with C3 (r=-0.487, P〈0.05; r=-0.395, P〈0.05). The Galectin-9 mRNA in SLE PBMCs was higher than that of the controls (P〈0.05). Conclusion TIM-3-Galectin-9 pathway may be involved in T cell immune regulation of SLE, and is related to disease activity.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2011年第4期220-223,共4页 Chinese Journal of Rheumatology
基金 围家“十一五”科技支撑计划(2008BA159B02)
关键词 红斑狼疮 系统性 半乳糖凝集素类 TH1细胞 Lupus erythematosus, systemic Galectins Thl cells
  • 相关文献

参考文献20

  • 1Monney L, Sabatos CA, Gaglia JL, et al. Thl-specific cell surface protein TiM-5 regulates macrophage activation andseverity of an autoimmune disease. Nature, 2002, 415: 536- 541.
  • 2Wang F, Wan L, Zhang C, et al. T1M-3-Galectin-9 pathway involves the suppression induced by CD4 ~CD25 ~ regulatory T cells, lmmunobiology, 2009, 214: 342-349.
  • 3Niwa H, Satoh T, Matsushima Y, et al. Stable form of Galectin- 9, a TIM-3 ligand, inhibits contact hypersensitivity andpsoriatic reactions: a potent therapeutic tool for Thl- and/or Thl7-mediated skin inflammation. Clin Immunol, 2009, 132: 184-194.
  • 4Kuchroo VK, Dardalhon V, Xiao S, et al. New roles for TIM family member in immune regulation. Nat Rev hnmunol, 2008, 8 : 577-580.
  • 5Kearley J, McMillan S J, Lloyd CM, et al. Th2-driven, allergen induced airway inflammation is reduced after treatment with anti-Tim-3 antibody in vivo..l EXD Med, 2007, 204: 1289-1294.
  • 6Sanchez-Fueyo A, Tian J, Piearella D, et al. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat lmmunol, 2003, 4: 1093-1101.
  • 7Li X, Chen G, Li Y, et al. Involvement of T cell Ig Mucin-3 (TIM-3) in the negative regulation of inflammatory boweldisease. Clin lmmunol, 2010, 134: 169-177.
  • 8Chae SC, Park YR, Shim SC, et al. The polymorphisms of Thlcell surface gene TIM-3 are associated in a Korean population with rheumatoid arthritis, hnmunol Lett, 2004, 95: 91-95.
  • 9Su EW, Lin JY, Kane LP, et al. TIM-1 and TIM-3 proteins in immune regulation. Cytokine, 2008, 44: 9-13.
  • 10Zhu C, Anderson AC, Sehubart A, et al. The Tim-3 ligand Galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol, 2005, 6." 1245-1252.

二级参考文献10

  • 1Baecher-Allan C,Viglietta V,Hafler DA.Human CD4+CD25+ regulatory T cells[].Seminars in Immunology.2004
  • 2Sakaguchi S,Sakaguchi N,Asano M,et al.Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[].Journal of Immunology.1995
  • 3Wong CK,Ho CY,Li EK,et al.Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus[].Lupus.2000
  • 4Kyriako AK,Mary KC.New pieces to the SLE cytokine puzzle[].Clinical Immunology.1999
  • 5Xu D,Liu H,Komai-Koma M,et al.CD4+ CD25+ regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice[].J Immunol.2003
  • 6Lit LC,,Wong CK,Li EKet al.Elevated gene expression of Th1/Th2associated transcription factors is correlated with disease activity in pa-tients with systemic lupus erythematosus[].The Journal of Rheumatology.2007
  • 7Hori,S,Nomura,T,Sakaguchi,S.Control of regulatory T cell development by the transcription factor Foxp3[].Science.2003
  • 8Chatila TA.Role of regulatory Tcells in human diseases[].The Journal of Allergy and Clinical Immunology.2005
  • 9Valencia X,Yarboro C,Illei G,et al.Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus[].J Immunol.2007
  • 10Norihiko W,Yi HW,Heung KL,et al.Hassall’s corpuscles instruct dendritic cells to induce CD4~+CD25~+ regulatory T cells in human thymus[].Nature.2005

同被引文献79

  • 1翁燕蓉,彭才智,曾铁云,杭春风.甲基泼尼松龙和环磷酰胺联合冲击治疗狼疮肾炎的护理干预[J].湖北医药学院学报,2012,31(1):76-78. 被引量:10
  • 2曾华松.小儿系统性红斑狼疮诊断及治疗[J].中国小儿急救医学,2006,13(6):579-582. 被引量:5
  • 3Hayashi T. Therapeutic strategies for SLE involving cytokines: mech- anism-oriented therapies especially 1FN-gamma targeting genethera- py. J Biomed Biotechno1,2010,2010. pii :461641.
  • 4Miyake K, Akahoshi M, Nakashima H. The subset balance in lupus nephritis. J Biomed Biotechno1,2011,2011:980286.
  • 5Hsu HC, Yang P,Wang J, et al. Interleukin 17-producingT helper cells and interleukin 17 orchestrate autoreactive germinal center de- velopment in autoinlmune BXD2 mice. Nat Immunol, 2008,9 ( 2 ) : 166-175.
  • 6Moisan J, Grenningloh R, Bettelli E, et al. Ets-1 is a negative regula- tor of Thl7 differentiation. J Exp Med,2007,204(12) :2825-2835.
  • 7Wong CK, Lit LC, Tam LS, et al. Hyperpmduction of IL-23 and IL- 17 in patients with systemic lupus erythematosus: implications for Thl7-mediated inflammation in auto-immunity. Clin Immunol,2008, 127 : 385-393.
  • 8Yang J,Chu Y,Yang X,et al. Thl7 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum,2009,60 (5) : 1472-1483.
  • 9Meyers JA, Mangini AJ, Nagai T, et al. Blockade of TLR9 agonist- induced type I interferons promotes inflammatory cytokine IFN-ganl- ma and IL-17 secretion hy activated human PBMC. Cytokine,2006, 35 (5-6) :235-246.
  • 10Lyssuk EY, Torgashina AV, Soloviev SK, et al. Reduced number and function of CD4 + CD25 high FoxP3 regulatory T cells in patients with systemic lupus erythematosus. Adv Exp Med Biol, 2007,601 : 113-119.

引证文献8

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部